Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FICB vs Fracture Block for Postoperative Pain in Hip Fracture
NCT04335461Phase 1Withdrawn
- Sponsor
- Montefiore Medical Center
- Start
- Aug 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine in hip fracture and postoperative pain (3 arms), sponsored by Montefiore Medical Center. Primary endpoint: Visual Analog Scale at 24 hours. Planned start Aug 2021; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
hip fracturepostoperative pain
Beyond the preview
Go deeper on NCT04335461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335461.